Paper73395
Acute phase reactant proteins in prostatic cancer.
Ward AM and 2 others. Br J Urol, 1977. Cited by 35 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Acute phase reactant proteins in prostatic cancer. Papers, record 73395. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/73395
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alpha-Globulins | Major topic |
| Estrogens | Major topic |
| Prostatic Neoplasms | Major topic |
| Proteins | Major topic |
| Acid Phosphatase | |
| Aged | |
| Ceruloplasmin | |
| Glycoproteins | |
| Haptoglobins | |
| Humans | |
| Male | |
| Neoplasm Metastasis | |
| Prealbumin | |
| alpha 1-Antitrypsin |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33,680,966 | Potential Roles of Acute Phase Proteins in Cancer: Why Do Cancer Cells Produce or Take Up Exogenous Acute Phase Protein Alpha1-Antitrypsin? | Front Oncol | 2021 | https://conductscience.org/library/papers/33680966 | PubMed |
| 24,886,427 | Serum concentration of alpha-1 antitrypsin is significantly higher in colorectal cancer patients than in healthy controls. | BMC Cancer | 2014 | https://conductscience.org/library/papers/24886427 | PubMed |
| 22,355,332 | iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer. | PLoS One | 2012 | https://conductscience.org/library/papers/22355332 | PubMed |
| 21,173,712 | Alpha1-antitrypsin deficiency carriers, serum alpha 1-antitrypsin concentration, and non-small cell lung cancer survival. | J Thorac Oncol | 2011 | https://conductscience.org/library/papers/21173712 | PubMed |
| 20,643,827 | Selenium-responsive proteins in the sera of selenium-enriched yeast-supplemented healthy African American and Caucasian men. | Cancer Epidemiol Biomarkers Prev | 2010 | https://conductscience.org/library/papers/20643827 | PubMed |
| 19,267,250 | C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older. | Cancer Causes Control | 2009 | https://conductscience.org/library/papers/19267250 | PubMed |
| 6,158,966 | Relationship of total serum sialic acid to sialylglycoprotein acute-phase reactants in malignant melanoma. | Br J Cancer | 1980 | https://conductscience.org/library/papers/6158966 | PubMed |
| 2,993,530 | Prognostic significance of serum alpha 1-acid glycoprotein in patients with glioblastoma multiforme: a preliminary communication. | J Neurol Neurosurg Psychiatry | 1985 | https://conductscience.org/library/papers/2993530 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HP | 3,240 | PubTator's text mining | https://conductscience.org/library/genes/3240 | NCBI Gene |
| SERPINA1 | 5,265 | PubTator's text mining | https://conductscience.org/library/genes/5265 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/73395
GET https://conductscience.org/api/papers/v1/73395/authors